US8318733B2ExpiredUtilityPatentIndex 98
Modulators of ATP-binding cassette transporters
Est. expiryNov 8, 2025(expired)· nominal 20-yr term from priority
Inventors:HADIDA-RUAH SARA SABINAHAMILTON MATTHEWMILLER MARK THOMASGROOTENHUIS PETER DIEDERIK JANZHOU JINGLANBEAR BRIAN RICHARDMCCARTNEY JASON
A61P 7/00A61P 35/00A61P 5/14A61P 7/02A61P 5/00A61P 43/00A61P 9/00A61P 5/16A61P 5/50A61P 5/18A61P 7/12A61P 3/10A61P 3/08A61P 3/06A61P 27/02A61P 25/14A61P 25/28A61P 25/00A61P 25/16A61P 3/00A61P 27/04A61P 1/00A61P 21/04A61P 19/04A61P 21/02A61P 21/00A61P 13/00A61P 11/00A61P 13/02A61P 19/00A61P 17/00A61P 13/12A61P 19/08C07D 317/12A61K 31/496A61K 31/443A61K 31/444C07K 14/4712A61K 31/506C07D 405/14C07D 405/12A61K 31/501A61K 31/4545A61K 45/06A61K 31/47A61K 31/4709A61K 31/5377A61K 31/4525G01N 33/6872A61K 31/497
98
PatentIndex Score
93
Cited by
80
References
44
Claims
Abstract
Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Claims
exact text as granted — not AI-modified1. A method of treating or lessening the severity of a disease in a patient, wherein said disease is dry-eye disease, said method comprising the step of administering to said patient an effective amount of a compound of formula I:
or a pharmaceutically acceptable salt thereof,
wherein:
Each R 1 is an optionally substituted C 1-6 aliphatic, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted C 3-10 cycloaliphatic, an optionally substituted 3 to 10 membered heterocycloaliphatic, carboxy, amido, amino, halo, or hydroxy, provided that at least one R 1 is an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl attached to the 5- or 6-position of the pyridyl ring;
Each R 2 is hydrogen, an optionally substituted C 1-6 aliphatic, an optionally substituted C 3-6 cycloaliphatic, an optionally substituted phenyl, or an optionally substituted heteroaryl;
Each R 3 and R′ 3 together with the carbon atom to which they are attached form an optionally substituted C 3-7 cycloaliphatic or an optionally substituted heterocycloaliphatic;
Each R 4 is an optionally substituted aryl or an optionally substituted heteroaryl; and
Each n is 1, 2, 3 or 4.
2. The method according to claim 1 , wherein one R 1 that is attached to 5- or 6-position of the pyridyl ring is aryl or heteroaryl, each optionally substituted with 1, 2, or 3 of R D ; wherein R D is -Z D R 9 ; wherein each Z D is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z D are optionally and independently replaced by —CO—, —CS—, —CONR E —, —CONR E NR E —, —CO 2 —, —OCO—, —NR E CO 2 —, —O—, —NR E CONR E —, —OCONR E —, —NR E NR E —, —NR E CO—, —S—, —SO—, —SO 2 —, —NR E —, —SO 2 NR E —, —NR E SO 2 —, or —NR E SO 2 NR E —; each R 9 is independently R E , halo, —OH, —NH 2 , NO 2 , —CN, —CF 3 , or —OCF 3 ; and each R E is independently hydrogen, an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl.
3. The method according to claim 2 , wherein the one R 1 attached to the 5- or 6-position of the pyridyl ring is phenyl optionally substituted with 1, 2, or 3 of R D .
4. The method according to claim 2 , wherein the one R 1 attached to the 5- or 6-position of the pyridyl ring is heteroaryl optionally substituted with 1, 2, or 3 of R D .
5. The method according to claim 2 , wherein one R 1 attached to the 5- or 6-position of the pyridyl ring is a 5 or 6 membered heteroaryl having 1, 2, or 3 heteroatom selected from the group consisting of oxygen, nitrogen, and sulfur, wherein the heteroaryl is substituted with 1 of R D , wherein R D is -Z D R 9 ; each Z D is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z D are optionally and independently replaced by —O—, —NHC(O)—, —C(O)NR E —, —SO 2 —, —NHSO 2 —, —NHC(O)—, —NR E SO 2 —, —SO 2 NH—, —SO 2 NR E —, —NH—, or —C(O)O—.
6. The method according to claim 5 , wherein one carbon unit of Z D is replaced by —O—, —NHC(O)—, —C(O)NR E —, —SO 2 —, —NHSO 2 —, —NHC(O)—, —SO—, —NR E SO 2 —, —SO 2 NH—, —SO 2 NR E —, —NH—, or —C(O)O—.
7. The method according to claim 2 , wherein R 9 is independently an optionally substituted aliphatic, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl, H, or halo.
8. The method according to claim 1 , wherein one R 1 that is attached to the 5- or 6-position of the pyridyl ring is cycloaliphatic or heterocycloaliphatic, each optionally substituted with 1, 2, or 3 of R D .
9. The method according to claim 8 , wherein one R 1 that is attached to the 5- or 6-position of the pyridyl ring is an optionally substituted C 3 -C 8 cycloalkyl or an optionally substituted C 3 -C 8 cycloalkenyl.
10. The method according to claim 1 , wherein the one R 1 attached to the 5- or 6-position of the pyridyl ring is selected from the group consisting of
11. The method according to claim 1 , wherein R 2 is hydrogen.
12. The method according to claim 1 , wherein R 3 and R′ 3 together with the carbon atom to which they are attached form an unsubstituted C 3-7 cycloaliphatic or an unsubstituted heterocycloaliphatic.
13. The method according to claim 12 , wherein R 3 and R′ 3 together with the carbon atom to which they are attached form an unsubstituted cyclopropyl, an unsubstituted cyclopentyl, or an unsubstituted cyclohexyl.
14. The method according to claim 1 , wherein R 4 is an aryl or heteroaryl optionally substituted with 1, 2, or 3 of -Z C R 8 , wherein each Z C is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z C are optionally and independently replaced by —CO—, —CS—, —CONR C —, —CONR C NR C —, —CO 2 —, —OCO—, —NR C CO 2 —, —O—, —NR C CONR C —, —OCONR C —, —NR C NR C —, —NR C CO—, —S—, —SO—, —SO 2 —, —NR C —, —SO 2 NR C —, —NR C SO 2 —, or —NR C SO 2 NR C —; each R 8 is independently R C , halo, —OH, —NH 2 , —NO 2 , —CN, or —OCF 3 ; and each R C is independently an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl.
15. The method according to claim 14 , wherein R 4 is an aryl optionally substituted with 1, 2, or 3 of -Z C R 8 .
16. The method according to claim 15 , wherein R 4 is an optionally substituted phenyl.
17. The method according to claim 14 , wherein R 4 is a heteroaryl optionally substituted with 1, 2, or 3 of -Z C R 8 .
18. The method according to claim 14 , wherein R 4 is one selected from
19. The method according to claim 1 , wherein said compound has formula (IV):
or a pharmaceutically acceptable salt thereof, wherein
R D is -Z D R 9 , wherein each Z D is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z D are optionally and independently replaced by —CO—, —CS—, —CONR E —, —CONR E NR E —, —CO 2 —, —OCO—, —NR E CO 2 —, —O—, —NR E CONR E —, —OCONR E —, —NR E NR E —, —NR E CO—, —S—, —SO—, —SO 2 —, —NR E —, —SO 2 NR E —, —NR E SO 2 —, or —NR E SO 2 NR E —;
R 9 is independently R E , halo, —OH, —NH 2 , —NO 2 , —CN, —CF 3 , or —OCF 3 ;
Each R E is independently hydrogen, an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl;
R 2 is C 1-4 aliphatic, C 3-6 cycloaliphatic, phenyl, or heteroaryl, each of which is optionally substituted, or R 2 is hydrogen;
R 3 and R′ 3 together with the carbon atom to which they are attached form a C 3-7 cycloaliphatic or a C 3-7 heterocycloaliphatic, each of which is optionally substituted with 1, 2, or 3 of -Z B R 7 , wherein each Z B is independently a bond, or an optionally substituted branched or straight C 1-4 aliphatic chain wherein up to two carbon units of Z B are optionally and independently replaced by —CO—, —CS—, —CONR B —, —CONR B NR B —, —CO 2 —, —OCO—, —NR B CO 2 —, —O—, —NR B CONR B —, —OCONR B —, —NR B NR B —, —NR B CO—, —S—, —SO—, —SO 2 —, —NR B —, —SO 2 NR B —, —NR B SO 2 —, or —NR B SO 2 NR B —;
Each R 7 is independently R B , halo, —OH, —NH 25 —NO 2 , —CN, —CF 3 , or —OCF 3 ;
Each R B is independently hydrogen, an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl;
Each R 4 is an aryl or heteroaryl, each of which is optionally substituted with 1, 2, or 3 of -Z C R 8 , wherein each Z C is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z C are optionally and independently replaced by —CO—, —CS—, —CONR C —, —CONR C NR C —, —CO 2 —, —OCO—, —NR C CO 2 —, —O—, —NR C CONR C —, —OCONR C —, —NR C NR C —, —NR C CO—, —S—, —SO—, —SO 2 —, —NR C —, —SO 2 NR C —, —NR C SO 2 —, or —NR C SO 2 NR C —;
Each R 8 is independently R C , halo, —OH, —NH 2 , —NO 2 , —CN, —CF 3 , or —OCF 3 ; and
Each R C is independently an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl.
20. The method according to claim 19 , wherein said compound has formula V-A or formula V-B:
or a pharmaceutically acceptable salt thereof,
wherein:
T is an optionally substituted C 1-2 aliphatic chain, wherein each of the carbon units is optionally and independently replaced by —CO—, —CS—, —COCO—, —SO 2 —, —B(OH)—, or —B(O(C 1-6 alkyl))-;
Each of R 1 ′ and R 1 ″ is an optionally substituted C 1-6 aliphatic, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted 3 to 10 membered cycloaliphatic, an optionally substituted 3 to 10 membered heterocycloaliphatic, carboxy, amido, amino, halo, or hydroxy;
R D1 is attached to carbon number 3″ or 4″;
each R D1 and R D2 is -Z D R 9 , wherein each Z D is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein up to two carbon units of Z D are optionally and independently replaced by —CO—, —CS—, —CONR E —, —CONR E NR E —, —CO 2 —, —OCO—, —NR E CO 2 —, —O—, —NR E CONR E —, —OCONR E —, —NR E NR E —, —NR E CO—, —S—, —SO—, —SO 2 —, —NR E —, —SO 2 NR E —, —NR E SO 2 —, or —NR E SO 2 NR E —;
R 9 is independently R E , halo, —OH, —NH 2 , —NO 2 , —CN, —CF 3 , or —OCF 3 ;
or R D1 and R D2 , taken together with atoms to which they are attached, form a 3-8 membered saturated, partially unsaturated, or aromatic ring with up to 3 ring members independently selected from the group consisting of O, NH, NR E , and S; and
each R E is independently hydrogen, an optionally substituted C 1-8 aliphatic group, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl.
21. The method according to claim 20 , wherein up to two methylene units of T are independently and optionally replaced by —CO—, —CS—, -B(OH), or —B(O(C 1-6 alkyl).
22. The method according to claim 20 , wherein T is an optionally substituted chain selected from the group consisting of —CH 2 — and —CH 2 CH 2 —.
23. The method according to claim 20 , wherein T is optionally substituted by F, Cl, C 1-6 alkyl, C 3-8 cycloalkyl, phenyl, naphthyl, —O—(C 1-6 alkyl), —O—(C 3-8 cycloalkyl), —O-phenyl, or C 3-8 spiroaliphatic.
24. The method according to claim 20 , wherein T is selected from the group consisting of —CH 2 —, —CH 2 CH 2 —, —CF 2 —, —C(CH 3 ) 2 —, —C(O)—,
—C(Phenyl) 2 —, —B(OH)—, and —CH(OEt)-.
25. The method according to claim 24 , wherein T is selected from the group consisting of —CH 2 —, —CF 2 —, and —C(CH 3 ) 2 —.
26. The method according to claim 20 , wherein Z D is independently a bond or an optionally substituted branched or straight C 1-6 aliphatic chain wherein one carbon unit of Z D is optionally replaced by —CO—, —SO—, —CO 2 —, —COO—, —OCO—, —CONR E —, —NR E CO—, NR E CO 2 —, —O—, —NR E SO 2 —, or —SO 2 NR E —.
27. The method according to claim 20 , wherein R D1 is -Z D R 9 , wherein R 9 is halo, —OH, —NH 2 , —CN, —CF 3 , —OCF 3 , or an optionally substituted group selected from the group consisting of C 1-6 aliphatic, C 3-8 cycloaliphatic, 3-8 membered heterocycloaliphatic, C 6-10 aryl, and 5-10 membered heteroaryl.
28. The method according to claim 27 , wherein R 9 is F, Cl, —OH, —CN, —CF 3 , or —OCF 3 .
29. The method according to claim 27 , wherein R 9 is selected from the group consisting of C 1-6 straight or branched alkyl or C 2-6 straight or branched alkenyl; wherein said alkyl or alkenyl is optionally substituted by 1 or 2 substituents independently selected from the group consisting of R E , oxo, halo, —OH, —NR E R E , —OR E , —COOR E , and —CONR E R E .
30. The method according to claim 27 , wherein R 9 is C 3-8 cycloaliphatic optionally substituted by 1 or 2 substituents independently selected from the group consisting of R E , oxo, halo, —OH, —NR E R E , —OR E , —COOR E , and —CONR E R E .
31. The method according to claim 30 , wherein R 9 is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or cycloheptyl.
32. The method according to claim 27 , wherein R 9 is a 3-8 membered heterocyclic with 1 or 2 heteroatoms independently selected from the group consisting of 0, NH, NR E , and S; wherein said heterocyclic is optionally substituted by 1 or 2 substituents independently selected from the group R E , oxo, halo, —OH, —NR E R E , —OR E , —COOR E , and —CONR E R E .
33. The method according to claim 32 , wherein R 9 is an optionally substituted 3-8 membered heterocyclic is
34. The method according to claim 32 , wherein R 9 is optionally substituted by 1 or 2 substituents independently selected from the group consisting of oxo, F, Cl, methyl, ethyl, i-propyl, t-butyl, —CH 2 OH, —CH 2 CH 2 OH, —C(O)OH, —C(O)NH 2 , —CH 2 O(C 1-6 alkyl), —CH 2 CH 2 O(C 1-6 alkyl), and —C(O)(C 1-6 alkyl).
35. The method according to claim 27 , wherein R 9 is 5-8 membered heteroaryl with 1 or two ring atom independently selected from the group consisting of O, S, and NR E ; wherein said heteroaryl is optionally substituted by 1 or 2 substituents independently selected from the group R E , oxo, halo, —OH, —NR E R E , —OR E , —COOR E , and —CONR E R E .
36. The method according to claim 35 , wherein R 9 is
37. The method according to claim 35 , wherein R 9 is optionally substituted by 1 or 2 substituents independently selected from the group consisting of F, Cl, methyl, ethyl, i-propyl, t-butyl, —CH 2 OH, —CH 2 CH 2 OH, —C(O)OH, —C(O)NH 2 , —CH 2 O(C 1-6 alkyl), —CH 2 CH 2 O(C 1-6 alkyl), and —C(O)(C 1-6 alkyl).
38. The method according to claim 20 , wherein R D1 and R D2 , taken together with carbons to which they are attached, form an optionally substituted 3-8 membered saturated, partially unsaturated, or aromatic ring with 0-2 ring atoms independently selected from the group consisting of O, NH, NR E , and S.
39. The method according to claim 38 , wherein R D1 and R D2 , taken together with phenyl containing carbon atoms 3″ and 4″, is
40. The method according to claim 38 , wherein R D1 and R D2 , taken together with phenyl containing carbon atoms 3″ and 4″, is optionally substituted by 1 or 2 substituents independently selected from the group consisting of R E , oxo, halo, —OH, —NR E R E , —OR E , —COOR E , and —CONR E R E .
41. The method according to claim 20 , wherein R D2 is selected from the group consisting of H, C 1-6 aliphatic, halo, —CN, —NH 2 , —CH 2 NH 2 , —OH, —O(C 1-6 aliphatic), —CH 2 OH, —SO 2 (C 1-6 aliphatic), —NH—SO 2 (C 1-6 aliphatic), —C(O)O(C 1-6 aliphatic), —C(O)OH, —NHC(O)(C 1-6 aliphatic), —C(O)NH 2 , —C(O)NH(C 1-6 aliphatic), and —C(O)N(C 1-6 aliphatic) 2 .
42. The method according to claim 20 , wherein R 1 ″ is hydrogen.
43. The method according to claim 20 , wherein R 1 ′ and R 1 ″ are both hydrogen.
44. The method according to claim 1 , wherein the compound is selected from
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.